Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title	Original Publication Date	Journal	Bone Marrow Disease
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes	May 2019	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Calculator-free point-of-care prognostication in myelodysplastic syndromes.	Jan 2019	Am J Hematol	Myelodysplastic Syndromes (MDS)
Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International PNH Registry	Jul 2020	European Journal of Haematology	Paroxysmal Nocturnal Hemoglobinuria (PNH)
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry	Jul 2020	Annals of Hematology	Paroxysmal Nocturnal Hemoglobinuria (PNH)
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry	May 2020	Annals of Hematology	Paroxysmal Nocturnal Hemoglobinuria (PNH)
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes	Feb 2021	Blood Advances	Myelodysplastic Syndromes (MDS)
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?	Jan 2021	Leukemia	Myelodysplastic Syndromes (MDS)
Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents	Oct 2019	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?	Jun 2023	Lancet	Myelodysplastic Syndromes (MDS)
Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?	Jul 2023	Lancet	Myelodysplastic Syndromes (MDS)